The report on the global tissue engineering and regeneration market analyses trends, covering 2024-2030. Segments include product type, material, and application across major regions. The study highlights key trends, challenges, ESG developments, and emerging technologies. It features market size, revenue forecasts, competitive landscape, and company profiles like Organogenesis and Johnson & Johnson. Ideal for stakeholders seeking insights into market dynamics and future growth prospects.
Global Tissue Engineering and Regeneration Market
Global Tissue Engineering and Regeneration Market
Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) — The “Tissue Engineering and Regeneration: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.
The report provides an overview of the global tissue engineering and regeneration market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.
Tissue engineering is a multidisciplinary field focused on producing biological substitutes to restore or enhance tissue and organ function. It integrates engineering, medicine and physiology, using components such as stem cells, scaffolds and bioactive molecules. Stem cells differentiate into specific cell types, scaffold supports their growth and bioactive molecules guide tissue formation.
Graft-based therapies, such as autologous allografts, xenografts and synthetic grafts, are commonly used in clinical applications, including skin, bone and soft tissue repair. Advances in biomaterials and scaffold design have improved graft results, allowing better imitation of natural tissue structures and improved regenerative outcomes through integration with growth factors and cellular therapies.
Current Market Scenario
The tissue engineering market is experiencing strong growth, primarily driven by the rising demand for regenerative medicine to treat chronic and degenerative diseases. Increasing research activities and rising product approvals are accelerating innovation and clinical adoption. Technological advances such as 3D bioprinting, smart biomaterials and AI integration augment treatment precision and expand application scope.
However, the market faces challenges, including high treatment costs and complex regulatory pathways that can delay commercialization. Additionally, emerging economies offer significant growth potential due to expanding healthcare infrastructure, supportive government policies and rising healthcare awareness.
Conclusion
The report concludes by analyzing the competitive landscape and providing the ranking/share of key global tissue engineering and regeneration companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.
Report Includes
47 data tables and 64 additional tables
Analyses of the trends in global markets for tissue engineering and regeneration technologies, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Estimates of the market’s size and revenue prospects, accompanied by a market share analysis by product type, material, application and region
Facts and figures pertaining to market dynamics, technological advances, regulations and the impact of macroeconomic factors
Insights derived from Porter’s Five Forces model, as well as global supply chain analysis
Patent analysis, featuring key granted and published patents
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Company profiles of major players within the industry, including Organogenesis Inc., Integra LifeSciences, Smith+Nephew, MiMedx Group Inc., and Johnson & Johnson Services Inc.
Company Profiles
Key Attributes:
Report Attribute
Details
No. of Pages
131
Forecast Period
2025 – 2030
Estimated Market Value (USD) in 2025
$5.4 Billion
Forecasted Market Value (USD) by 2030
$9.8 Billion
Compound Annual Growth Rate
12.8%
Regions Covered
Global
Key Topics Covered:
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Porter’s Five Forces Analysis in the Tissue Engineering and Regeneration Market
Macroeconomic Factor Analysis
Aging Population
Regulatory Environment
Government Policy and Collaboration
The U.S. Tariff Scenario
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Demand for Regenerative Medicine
Growing Research and Approvals in Tissue Engineering
Increasing Venture Capital Funding
Market Restraints
High Cost Associated with Treatment
Complex Regulatory Pathway
Market Opportunities
Technological Advances
Emerging Economies
Chapter 4 Regulatory Landscape
The U.S.
Europe
Asia-Pacific
Chapter 5 Impact of AI Adoption on the Tissue Engineering and Regeneration Market
Overview
Case Studies
Problem
Solution
Outcome
AI Adoption: Trends
Adoption Trends in North America
Adoption Trends in Europe
Adoption Trends in the Rest of the World
AI Disruption Trends
Impact of AI on Various Stages of the Value Chain
Market Spending and Investment Scenario
VC Investment in AI
Chapter 6 Emerging Technologies and Developments
Emerging Technologies
3D Bioprinting
Organ-on-a-Chip
Smart Biomaterial
Artificial Intelligence
Clinical Trials Analysis
Key Takeaways
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Patent Analysis
Key Takeaways
Patents, by Year
Patents by Top Applicant
Patents by Top Owner
Patents by Jurisdiction
Chapter 7 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Scaffolds
Biological Scaffolds
Synthetic Scaffolds
Grafts
Allogenic
Autogenic
Synthetic
Xenogeneic
Market Analysis by Material
Key Takeaways
Biologically Derived Material
Synthetic Material
Market Analysis by Application
Key Takeaways
Orthopedics and Musculoskeletal Disorders
Dermatology and Wound Care
Dental Disorders
Cardiovascular Diseases
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Chapter 8 Competitive Intelligence
Chapter 9 Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
Chapter 10 Appendix
For more information about this report visit
About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
/tpg/sources/1569a165-a771-47f4-b1c4-fc3f898f6de3.jpeg "Mumbai Emerges As Global Hub For Tech And Education")
